We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+17.95%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$10.2B
AUM Growth
+$1.96B
(+24%)
Cap. Flow
+$643M
Cap. Flow
% of AUM
6.28%
Top 10 Holdings %
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$264M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$122M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$92.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$52M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$92.8M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$32.9M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$15.4M |
| 4 |
Lockheed Martin
LMT
|
+$14M |
| 5 |
Apple
AAPL
|
+$9.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.61% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 3.29% |
| 4 | Energy | 3.1% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
526
DELISTED
Clovis Oncology, Inc.
CLVS
| $923K | 0.01% |
192,208
-136,295
| -41% | -$689K |
|
527
Rocket Companies
RKT
$40.2B
| $919K | 0.01% |
45,447
+12,527
| +38% | +$264K |
|
|
BHVN
528
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $915K | 0.01% |
10,680
-22,928
| -68% | -$1.94M |
|
|
BPMC
529
DELISTED
Blueprint Medicines
BPMC
| $912K | 0.01% |
8,128
-21,730
| -73% | -$2.29M |
|
530
Karyopharm Therapeutics
KPTI
$46.2M
| $912K | 0.01% |
3,929
-5,386
| -58% | -$1.25M |
|
531
Viatris
VTRS
$20.5B
| $895K | 0.01% |
47,774
+13,735
| +40% | +$224K |
|
532
Matsons
MATX
$6.47B
| $893K | 0.01% |
15,673
+5,584
| +55% | +$305K |
|
533
Ultragenyx Pharmaceutical
RARE
$2.51B
| $891K | 0.01% |
6,433
-20,440
| -76% | -$2.42M |
|
534
United Airlines
UAL
$42.7B
| $890K | 0.01% |
20,570
+5,536
| +37% | +$224K |
|
535
Beam Therapeutics
BEAM
$2.81B
| $884K | 0.01% |
+10,825
| New | +$532K |
|
536
CBRE Group
CBRE
$43.4B
| $883K | 0.01% |
14,072
-235
| -2% | -$13.3K |
|
|
FLIR
537
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $882K | 0.01% |
20,115
-536
| -3% | -$20.7K |
|
|
ALLK
538
DELISTED
Allakos
ALLK
| $881K | 0.01% |
6,291
-14,745
| -70% | -$1.53M |
|
539
PTC Therapeutics
PTCT
$5.75B
| $876K | 0.01% |
14,347
-29,166
| -67% | -$1.72M |
|
540
Tenable Holdings
TENB
$4.02B
| $875K | 0.01% |
+16,749
| New | +$664K |
|
541
Alkermes
ALKS
$8.38B
| $873K | 0.01% |
43,766
-70,266
| -62% | -$1.29M |
|
542
Iovance Biotherapeutics
IOVA
$1.96B
| $866K | 0.01% |
18,663
-43,929
| -70% | -$1.74M |
|
543
SouthState Bank Corp
SSB
$10.4B
| $859K | 0.01% |
11,883
-6,187
| -34% | -$406K |
|
|
MRTX
544
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $859K | 0.01% |
3,912
-11,109
| -74% | -$2.4M |
|
545
Allogene Therapeutics
ALLO
$639M
| $858K | 0.01% |
33,998
-27,279
| -45% | -$889K |
|
546
Texas Capital Bancshares
TCBI
$4.42B
| $858K | 0.01% |
14,427
-10,765
| -43% | -$532K |
|
547
Teladoc Health
TDOC
$1.21B
| $857K | 0.01% |
4,287
+901
| +27% | +$183K |
|
548
Caterpillar
CAT
$407B
| $855K | 0.01% |
4,695
+1,304
| +38% | +$221K |
|
549
Veeva Systems
VEEV
$33.9B
| $853K | 0.01% |
3,133
+561
| +22% | +$157K |
|
550
Boston Scientific
BSX
$71.1B
| $849K | 0.01% |
23,603
-2,217
| -9% | -$79.9K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rafferty Asset Management held 1,081 positions worth $10.2B, up 24% from $8.27B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Rafferty Asset Management deployed $643M of net new capital in Q4 2020, opening 132 new positions and adding to 418 existing holdings. Its largest new stake was Keurig Dr Pepper: 119,771 shares worth $3.83M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $92.8M trimmed.
- Rafferty Asset Management's largest Q4 2020 buy was Keurig Dr Pepper: 119,771 shares worth $3.83M.
- Rafferty Asset Management added most to iShares Russell 2000 ETF in Q4 2020, an estimated $264M increase.
- Rafferty Asset Management's biggest Q4 2020 reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, cutting an estimated $92.8M.
- Rafferty Asset Management fully exited iShares MSCI EAFE ETF in Q4 2020, selling an estimated $4.41M.
- Rafferty Asset Management's ten largest holdings make up 43% of its $10.2B portfolio in Q4 2020.
- Rafferty Asset Management opened 132 new positions and closed 74 in Q4 2020.
- Rafferty Asset Management's portfolio value rose 24% quarter-over-quarter to $10.2B.
Based on Rafferty Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.